Iridoid extracts from Ajuga iva increase the antioxidant enzyme activities in red blood cells of rats fed a cholesterol-rich diet

被引:19
作者
Bouderbala, Sherazede [1 ]
Prost, Josiane [2 ]
Lacaille-Dubois, Marie Aleth [3 ]
Bouchenak, Malika [1 ]
机构
[1] Univ Oran Es Senia, Fac Sci, Dept Biol, Lab Nutr Clin & Metab, Oran 31000, Algeria
[2] Univ Bourgogne, Fac Sci Gabriel, UPRES Lipides & Nutr, F-21100 Dijon, France
[3] Univ Bourgogne, Lab Pharmacognosie, Fac Pharm, Unite Mol Interet Biol,UMIB,UPRES EA 3660, F-21100 Dijon, France
关键词
Hypercholesterolemic rat; Ajuga iva; Iridoids; TBARS; Antioxidant enzymes; INDUCED DIABETIC-RATS; LIPID-PEROXIDATION; OXIDATIVE STRESS; FREE-RADICALS; RAPID METHOD; LIPOPROTEINS; DENSITY; DEFENSE; PROFILE;
D O I
10.1016/j.nutres.2010.05.004
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The lyophilized aqueous extract of Ajuga iva (Ai) is able to reduce oxidative stress, which may prevent lipid peroxidation in hypercholesterolemic rats. Iridoids (1) were isolated from A. We hypothesized that the antioxidant defense status in red blood cells (RBC) and tissues in rats fed a cholesterol-rich diet and treated with Ai may be correlated to these compounds. Male Wistar rats (n = 32) weighing 120 +/- 5 g were fed a diet containing 1% cholesterol for 15 days. After this phase, hypercholesterolemic (HC) rats were divided into groups, fed the same diet, and received either the same or different doses (5, 10, or 15 mg/kg body weight by intraperitoneal injection) of I for 15 days. Compared with the HC group, total cholesterol value was 1.4- and 1.2-fold lower in the I-5-HC and I-10-HC groups. Serum thiobarbituric acid reactive substance content was 2.3-, 2.9-, and 3-fold lower in the I-5-HC, I-10-HC, and I-15-HC groups compared with the HC group. In RBC, glutathione peroxidase, glutathione reductase, and superoxide dismutase activities were significantly higher in the I-5-HC, I-10-HC, and I-15-HC groups than the HC group. Liver, heart, and muscle glutathione peroxidase and superoxide dismutase activities were significantly higher in the groups treated with 1 than the HC group. Muscle glutathione reductase activity was increased 1.4-fold in the I-5-HC, 1.5-fold in the I-10-HC, and 1.5-fold in the I-15-HC group. In HC rats, different doses of 1 increase the antioxidant enzyme activities in RBC and act differently in tissues. Treatment with I may play an important role in suppressing oxidative stress caused by dietary cholesterol and, thus, may be useful for the prevention and/or early treatment of hypercholesterolemia. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 36 条
[1]  
ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
[2]  
[Anonymous], 1974, Catalase. Methods Enzym. Anal., DOI DOI 10.1016/B978-0-12-091302-2.50032-3
[3]   HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[4]   Antihypercholesterolaemic and antioxidant activity assessment of some plants used as remedy in Turkish folk medicine [J].
Avci, Gulcan ;
Kupeli, Esra ;
Eryavuz, Abdullah ;
Yesilada, Erdem ;
Kucukkurt, Ismail .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 107 (03) :418-423
[5]  
Bergmeyer HU., 1983, METHODS ENZYMATIC AN, VVI., P258
[6]  
BLACHE D, 1992, LUNAR-BASED CHEMICAL ANALYSIS LABORATORY, P82
[7]   Changes in antioxidant defense status in hypercholesterolemic rats treated with Ajuga iva [J].
Bouderbala, S. ;
Lamri-Senhadji, M. ;
Prost, J. ;
Lacaille-Dubois, M. A. ;
Bouchenak, M. .
PHYTOMEDICINE, 2008, 15 (6-7) :453-461
[8]   RAPID METHOD FOR THE ISOLATION OF 2 PURIFIED SUBFRACTIONS OF HIGH-DENSITY LIPOPROTEINS BY DIFFERENTIAL DEXTRAN SULFATE-MAGNESIUM CHLORIDE PRECIPITATION [J].
BURSTEIN, M ;
FINE, A ;
ATGER, V ;
WIRBEL, E ;
GIRARDGLOBA, A .
BIOCHIMIE, 1989, 71 (06) :741-746
[9]  
BURSTEIN M, 1970, J LIPID RES, V11, P583
[10]   Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract [J].
Cho, SY ;
Park, JY ;
Park, EM ;
Choi, MS ;
Lee, MK ;
Jeon, SM ;
Jang, MK ;
Kim, MJ ;
Park, YB .
CLINICA CHIMICA ACTA, 2002, 317 (1-2) :109-117